Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (4) : 485-490    https://doi.org/10.1007/s11684-009-0089-3
Research articles
Effect of pEGFP-survivin on GBC-SD cell growth and chemotherapy sensitivity
Hanbin SHEN MD1,Bin ZHANG MBA1,Song ZHAO BM1,Qichang ZHENG MD2,Jianping GONG MD3,Xiaotang CAI BM4,
1.Department of General Surgery, The Fifth Hospital of Wuhan, Wuhan 430050, China; 2.Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; 3.Department of Intestines and Stomach Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 4.Department of Surgery, The 477th Hospital of People''s Liberation Army, China;
 Download: PDF(215 KB)  
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract This paper is aimed to investigate the effect of survivin shRNA on chemotherapy resistance in human gallbladder carcinoma GBC-SD cells. The viability of human gallbladder carcinoma GBC-SD, GBC-SD/enhanced green fluorescent protein (EGFP), and GBC-SD/survivin cells was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and mRNA and protein of survivin were tested by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. After the cells were treated with cisplatin (DDP) (3.0 μg/mL) for the same time, cell survival rate and IC50 was detected with MTT, cell apoptosis was detected with fluorescence-activated cell sorting (FACS), and the nuclear alteration was observed by TdT-mediated deoxyuridine triphosphate nick end labeling (TUNEL). In addition, caspase-3 activity was detected by using colorimetric method. Cell viability was decreased significantly in GBC-SD/survivin cells, and survivin expression was decreased significantly (mRNA and protein of survivin were decreased by 74.7% and 71.5%, respectively). After treatment with DDP, cell survival rate and IC50 was decreased significantly (2.03±0.24 μg/mL) in GBC-SD/survivin cells, while apoptotic rate (84.3%) was elevated significantly as compared with the other two groups. There were brown apoptotic nuclei in all the cells. Caspase-3 activity in all the cells was increased at first and then decreased, but the caspase-3 activity in GBC-SD/survivin cells was significantly higher than the other two groups. The survivin shRNA could down-regulate the expression of survivin in GBC-SD cells significantly and improve the sensibility to chemotherapy.
Keywords survivin      shRNA      chemotherapy      sensibility      GBC-SD      
Issue Date: 05 December 2009
 Cite this article:   
Song ZHAO BM,Jianping GONG MD,Hanbin SHEN MD, et al. Effect of pEGFP-survivin on GBC-SD cell growth and chemotherapy sensitivity[J]. Front. Med., 2009, 3(4): 485-490.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0089-3
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I4/485
Tamm I, Wang Y, Sausville E, Scudiero D A, Vigna N, Oltersdorf T, Reed J C. IAP-familyprotein survivin inhibits caspase activity and apoptosis induced byFas (CD95), Bax, caspase, and anticancer drugs. Cancer Res, 1998, 58(23): 5315–5320
Altieri D C. Validating survivin as a cancer therapeutic target. Nat Rev Cancer, 2002, 3(1): 46–53

doi: 10.1038/nrc968
Olie R A, Simoes-Wust A P, Baumann B, Leech S H, Fabbro D, Stahel R A, Zangemeister-Wittke U. A novel antisenseoligonucleotide targeting survivin expression induce apoptosis sensitizeslung cancer cells to chemotherapy. CancerRes, 2000, 60(11): 2805–2809
Pennati M, Colella G, Folini M, Citti L, Daidone M G, Zaffaroni N. Ribozyme-mediatedattenuation of survivin expression sensitizes human melanoma cellsto cisplatin-induced apoptosis. J ClinInvest, 2002, 109(2): 285–286
Wu L, Wang Y, Tian D. Knockdown of survivin expression by siRNA induces apoptosisof hepatocellular carcinoma cells. J HuazhongUniv Sci Technol Med Sci, 2007, 27(4): 403–406

doi: 10.1007/s11596-007-0413-6
Wang Y, Zhu Z, Zeng F, Wang L, Wu Y, Xia W, Xing S. Expression and prognostic significanceof survivin in the progression of bladder transitional cell cancer. J Huazhong Univ Sci Technol Med Sci, 2007, 27(4): 444–447

doi: 10.1007/s11596-007-0424-3
Ferreira C G, Epping M, Kruyt F A, Giaccone G. Apoptosis:target of cancer therapy. Clin Cancer Res, 2002, 8(7): 2024–2034
Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancerand lymphoma. Nat Med, 1997, 3(8): 917–921

doi: 10.1038/nm0897-917
Shin S, Sung B J, Cho Y S, Kim H J, Ha N C, Hwang J I, Chung C W, Jung Y K, Oh B H. An anti-apoptoticprotein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry, 2001, 40(4): 1117–1123

doi: 10.1021/bi001603q
Joseph B, Lewensohn R, Zhivotovsky B. Role of apoptosis in the response of lung carcinomasto anti-cancer treatment. Ann N Y AcadSci, 2000, 926: 204–216
Sarela A I, Verbeke C S, Ramsdale J, Davies C L, Markham A F, Guillou P J. Expression of survivin, a novel inhibitor of apoptosisand cell cycle regulatory protein, in pancreatic adenocarcinoma. Br J Cancer, 2002, 86(6): 886–892

doi: 10.1038/sj.bjc.6600133
Tenllado F, Llave C, Díaz-Ruíz J R. RNA interference as a newbiotechnological tool for the control of virus diseases in plants. Virus Res, 2004, 102(1): 85–96

doi: 10.1016/j.virusres.2004.01.019
Tijsterman M, Plasterk R H. Dicers at RISC; the mechanismof RNAi. Cell, 2004, 117(1): 1–3

doi: 10.1016/S0092-8674(04)00293-4
Kwon M, Scholey J M. Spindle mechanics and dynamicsduring mitosis in Drosophila. Trends Cell Biol, 2004, 14(4): 194–205

doi: 10.1016/j.tcb.2004.03.003
Pham J W, Pellino J L, Lee Y S, Carthew R W, Sontheimer E J. A Dicer-2-dependent 80s complexcleaves targeted mRNAs during RNAi in Drosophila. Cell, 2004, 117(1): 83–94

doi: 10.1016/S0092-8674(04)00258-2
Cheng C P, Pogany J, Nagy P D. Mechanism of DI RNA formation in tombusviruses: dissectingthe requirement for primer extension by the tombusvirus RNA dependentRNA polymerase in vitro. Virology, 2002, 304(2): 460–473

doi: 10.1006/viro.2002.1713
Schwarz D S, Hutvagner G, Du T, Xu Z, Aronin N, Zamore P D. Asymmetry in the assembly of the RNAi enzyme complex. Cell, 2003, 115(2): 199–208

doi: 10.1016/S0092-8674(03)00759-1
Arenz C, Schepers U. RNA interference: from anancient mechanism to a state of the art therapeutic application? Naturwissenschaften, 2003, 90(8): 345–359

doi: 10.1007/s00114-003-0441-4
Raff M. Cellsuicide for beginners. Nature, 1998, 396(6707): 119–122

doi: 10.1038/24055
Chen R H, Chang T Y. Involvement of caspase familyprotease in transforming growth factor-beta induced apoptosis. Cell Growth Differ, 1997, 8(7): 82–87
Fujikawa K, Shiraki K, Sugimoto K, Ito T, Yamanaka T, Takase K, Nakano T. Reduced expression of ICE/caspase-1and CPP32/caspase-3 in human hepatocellular carcinoma. Anticancer Res, 2000, 20(3B): 1927–1932
Endo K, Ashida K, Miyake N, Terada T. E-cadheringene mutations human intrahepatic holangiocarcinoma. J Pathol, 2001, 193(3): 310–317

doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH816>3.0.CO;2-K
Joo Y E, Park C S, Kim H S, Choi S K, Rew J S, Kim S J. Prognostic significance of E-cadherin/catenin complex expressionin gastric cancer. J Korean Med Sci, 2000, 15(6): 655–666
[1] Ling Wang, Ying Wang, Jiong Hu, Yuqian Sun, He Huang, Jing Chen, Jianyong Li, Jun Ma, Juan Li, Yingmin Liang, Jianmin Wang, Yan Li, Kang Yu, Jianda Hu, Jie Jin, Chun Wang, Depei Wu, Yang Xiao, Xiaojun Huang. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study[J]. Front. Med., 2019, 13(3): 365-377.
[2] Yunfeng Fu, Xinyu Wang, Zimin Pan, Xing Xie. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases[J]. Front Med, 2014, 8(1): 91-95.
[3] Cuihong ZHENG, Yunxia WU, Guangying HUANG, Wei WANG. Gene silencing efficiency of shRNA expression vectors targeting Cx43 in vitro[J]. Front Med Chin, 2009, 3(2): 130-135.
[4] YU Xiaobing, DAI Hong, LU Yingyi, LONG Li. Photodynamic therapy combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization[J]. Front. Med., 2007, 1(4): 405-409.
[5] XIONG Ying, GUO Wen, LI Ting, LI Ke. Influence of Survivin-targeted siRNA on the biological features of colorectal carcinoma cells[J]. Front. Med., 2007, 1(3): 304-307.
[6] RAO Rongsheng, CHEN Wenxue, ZHOU Xinwen, ZHOU Zheng, LI Xiaojun, ZENG Zhiping. Clinical outcomes of ATP-tumor chemosensitivity assay directed chemotherapy in hepatocellular carcinoma[J]. Front. Med., 2007, 1(2): 157-160.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed